 Alternatively analysis of 27-hydroxycholesterol and 7 alpha hydroxycholesterol can be used.Genetic testing of the CYP27A1 gene is confirmatory and is increasingly being used as a first line test as part of symptom specific gene panels (genetic eye disease, ataxia, dementia).The standard treatment is chenodeoxycholic acid (CDCA) replacement therapy.